XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

128 hedge funds and large institutions have $1.05B invested in Acceleron Pharma in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

less funds holding in top 10

Funds holding in top 10:

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

74% less call options, than puts

Call options by funds: $1.87M | Put options by funds: $7.33M

Holders
128
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.87M
Puts
$7.33M
Net Calls
Net Calls Change

Top Buyers

1 +$16.2M
2 +$14.5M
3 +$10M
4
PC
Polar Capital
United Kingdom
+$9.88M
5
Axa
Axa
France
+$9.83M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$144M
2
$122M
3
$117M
4
$61.7M
5
$51.1M
6
$47.2M
7
$38.2M
8
$34.4M
9
$32.7M
10
$21.6M
11
$21.3M
12
$21.3M
13
$19.9M
14
$18.4M
15
$16.9M
16
$16.5M
17
$15.8M
18
$15M
19
$14.6M
20
$14.1M
21
$13.2M
22
$11.8M
23
$11.6M
24
$9.98M
25
$9.83M